Moderna Charitable Foundation Inc
The Moderna Charitable Foundation Inc is a 501(c)(3) corporate foundation established by Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. Based in Cambridge, Massachusetts, the foundation was launched in April 2022 to support organizations and causes that create long-lasting change for a healthier world, with particular emphasis on communities impacted by COVID-19.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$31.1M
Annual Giving
$6.9M
Grant Count
10
Avg Grant Size
$692K
Mission & Focus Areas
The foundation's mission is to support organizations and causes that:
- Promote public health and access to quality healthcare
- Advance scientific education and innovation
- Advocate for diversity and inclusion
- Address ongoing needs in communities impacted by COVID-19
- Support societal conditions exacerbated by the pandemic and inequalities revealed during this period
The foundation focuses on supporting 501(c)(3) organizations and similarly organized nonprofit organizations outside the U.S. for the benefit of local and global communities, with particular emphasis on underserved populations.
Grantmaking
The Moderna Foundation operates on a semiannual grant cycle with two application periods each year. Each cycle includes a defined application window and structured review process.
Review Cycle
with two application periods each year. Each cycle includes a defined application window and structured review process.
How to Apply
**
Ready to take the next step with Moderna Charitable Foundation Inc?
Geographic Focus
Where this funder awards grants
The foundation funds organizations in the United States and internationally. In the U.S., there is particular emphasis on the greater Boston, Massachusetts area. Geographic funding distribution includes Cambridge, New York, Boston, and other U.S. and international cities.
Grant Distribution by State
Cities
Financial History
Multi-year comparison from IRS filings
Assets & Giving:
- Total Assets (2023): $37.8 million
- Total Assets (2022): $42.9 million
- Total Liabilities (2023): $2.58 million
- Total Revenue (2023): $1.99 million
- Total Expenses (2023): $8.78 million
- Total Revenue (2022): $50.7 million
- Total Expenses (2022): $8.6 million
- Total Giving (2024): $6.9 million
Initial Endowment: The foundation was established with an initial up-front endowment of $50 million approved by the Moderna Board of Directors.
| Metric | 2024 | 2022 | 2021 |
|---|---|---|---|
| Total Assets | $31,132,929 | $42,873,695 | — |
| Revenue | $1,763,397 | $50,672,875 | — |
| Expenses | $7,138,019 | $8,643,763 | — |
| Qualifying Distributions | $7,113,868 | $8,593,420 | — |
| Net Investment Income | $1,763,397 | $672,875 | — |
| Distributable Amount | $1,692,260 | $1,833,195 | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
21 grants across all recorded years
Open Grants
2 open opportunities from Moderna Charitable Foundation Inc
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Leadership team and compensation from IRS filings
Noubar Afeyan - Co-founder and Chairman of Moderna
Stéphane Bancel - Chief Executive Officer of Moderna
The foundation was established by the Moderna Board of Directors.
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| CATHERINE CRONIN | DIRECTOR | 1 | — |
| TRACEY FRANKLIN | DIRECTOR | 1 | — |
| STEPHEN HOGE | DIRECTOR (UNTIL 11/2024) | 1 | — |
| SHANNON KLINGER | DIRECTOR AND PRESIDENT | 2 | — |
| PAUL BARANELLO | TREASURER | 4 | — |
| BRIAN SANDSTROM | SECRETARY | 4 | — |
| ROSE LOUGHLIN | DIRECTOR (AS OF 11/2024) | 1 | — |
Recent News & Activity
Recent developments and announcements
The Moderna Charitable Foundation was launched on April 4, 2022, with initial grants of approximately $5 million awarded to local and global nonprofits supporting groups and causes disproportionately affected by COVID-19. The foundation represents an extension of the societal impact Moderna made through its COVID-19 vaccine development and reflects the company's continued commitment to communities impacted by the pandemic and to supporting causes that employees care about.
Moderna Launches New Charitable FoundationData last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with Moderna Charitable Foundation Inc on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities